TreeWAS – Variant ID: rs6811556

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43.0 Tricyclic and tetracyclic antidepressants	0.083	0.917	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.077	0.923	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.074	0.926	0.000
T43.6 Psychostimulants with abuse potential	0.068	0.932	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.067	0.933	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.064	0.936	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.062	0.938	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.062	0.938	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.061	0.939	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.059	0.941	0.000
T40.2 Other opioids	0.059	0.941	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.059	0.941	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.058	0.942	0.000
T43.9 Psychotropic drug, unspecified	0.058	0.942	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.058	0.942	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.057	0.943	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.056	0.944	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.055	0.945	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.054	0.946	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.054	0.946	0.000
T36 Poisoning by systemic antibiotics	0.054	0.946	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.053	0.947	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.052	0.948	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.052	0.948	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.051	0.949	0.000
T45.0 Antiallergic and antiemetic drugs	0.051	0.949	0.000
T38.0 Glucocorticoids and synthetic analogues	0.051	0.949	0.000
T45.5 Anticoagulants	0.050	0.950	0.000
T39.0 Salicylates	0.050	0.950	0.000
T38.1 Thyroid hormones and substitutes	0.049	0.951	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.049	0.951	0.000
T38.9 Other and unspecified hormone antagonists	0.048	0.952	0.000
T38.7 Androgens and anabolic congeners	0.048	0.952	0.000
T38.4 Oral contraceptives	0.048	0.952	0.000
T38.2 Antithyroid drugs	0.048	0.952	0.000
T38.5 Other oestrogens and progestogens	0.048	0.952	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.047	0.952	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.047	0.953	0.000
T47.6 Antidiarrhoeal drugs	0.047	0.953	0.000
T47.0 Histamine H(2)-receptor antagonists	0.047	0.953	0.000
T40.4 Other synthetic narcotics	0.046	0.954	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.046	0.954	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.046	0.954	0.000
T40.3 Methadone	0.046	0.954	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.045	0.955	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.045	0.955	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.045	0.955	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.045	0.955	0.000
T40.8 Lysergide [LSD]	0.045	0.955	0.000
T40.7 Cannabis (derivatives)	0.045	0.955	0.000
T40.0 Opium	0.045	0.955	0.000
T40.1 Heroin	0.045	0.955	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.045	0.955	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.045	0.955	0.000
T47.7 Emetics	0.045	0.955	0.000
T47.5 Digestants	0.045	0.955	0.000
T47.3 Saline and osmotic laxatives	0.045	0.955	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.044	0.956	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.044	0.956	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.044	0.956	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.044	0.956	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.044	0.956	0.000
T44.0 Anticholinesterase agents	0.044	0.956	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.044	0.956	0.000
T47.2 Stimulant laxatives	0.044	0.956	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.044	0.956	0.000
T47.4 Other laxatives	0.044	0.956	0.000
T41.2 Other and unspecified general anaesthetics	0.043	0.957	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.043	0.957	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.042	0.958	0.000
T45.8 Other primarily systemic and haematological agents	0.042	0.958	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.042	0.958	0.000
T45.6 Fibrinolysis-affecting drugs	0.042	0.958	0.000
T45.4 Iron and its compounds	0.042	0.958	0.000
T45.3 Enzymes, not elsewhere classified	0.042	0.958	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.042	0.958	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.042	0.958	0.000
T39.1 4-Aminophenol derivatives	0.042	0.958	0.000
T46.1 Calcium-channel blockers	0.042	0.958	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.042	0.958	0.000
T37.5 Antiviral drugs	0.042	0.958	0.000
T37.4 Anthelminthics	0.042	0.958	0.000
T37.3 Other antiprotozoal drugs	0.042	0.958	0.000
T37.1 Antimycobacterial drugs	0.042	0.958	0.000
T37.0 Sulphonamides	0.042	0.958	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.041	0.959	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.041	0.959	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.041	0.959	0.000
T46.7 Peripheral vasodilators	0.041	0.959	0.000
T41.5 Therapeutic gases	0.040	0.960	0.000
T41.4 Anaesthetic, unspecified	0.040	0.960	0.000
T41.3 Local anaesthetics	0.040	0.960	0.000
T41.1 Intravenous anaesthetics	0.040	0.960	0.000
T41.0 Inhaled anaesthetics	0.040	0.960	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.040	0.960	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.040	0.960	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.040	0.960	0.000
T36.3 Macrolides	0.039	0.960	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.039	0.961	0.000
T36.0 Penicillins	0.039	0.961	0.000
T40.5 Cocaine	0.039	0.961	0.000
T49.9 Topical agent, unspecified	0.039	0.961	0.000
T49.8 Other topical agents	0.039	0.961	0.000
T49.7 Dental drugs, topically applied	0.039	0.961	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.039	0.961	0.000
T49.5 Ophthalmological drugs and preparations	0.039	0.961	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.039	0.961	0.000
T49.3 Emollients, demulcents and protectants	0.039	0.961	0.000
T49.2 Local astringents and local detergents	0.039	0.961	0.000
T49.1 Antipruritics	0.039	0.961	0.000
T36.9 Systemic antibiotic, unspecified	0.039	0.961	0.000
T36.7 Antifungal antibiotics, systemically used	0.039	0.961	0.000
T36.6 Rifamycins	0.039	0.961	0.000
T36.5 Aminoglycosides	0.039	0.961	0.000
T36.2 Chloramphenicol group	0.039	0.961	0.000
T39.4 Antirheumatics, not elsewhere classified	0.039	0.961	0.000
T39.2 Pyrazolone derivatives	0.039	0.961	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.038	0.961	0.000
T36.4 Tetracyclines	0.038	0.961	0.000
T50.1 Loop [high-ceiling] diuretics	0.038	0.962	0.000
T42.0 Hydantoin derivatives	0.038	0.962	0.000
T36.8 Other systemic antibiotics	0.038	0.962	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.037	0.963	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.037	0.963	0.000
T42.2 Succinimides and oxazolidinediones	0.037	0.963	0.000
T42.3 Barbiturates	0.037	0.963	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.037	0.963	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.037	0.963	0.000
T42.1 Iminostilbenes	0.036	0.964	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.036	0.964	0.000
T45.2 Vitamins, not elsewhere classified	0.034	0.966	0.000
T50.7 Analeptics and opioid receptor antagonists	0.034	0.966	0.000
T50.5 Appetite depressants	0.034	0.966	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.034	0.966	0.000
T50.0 Mineralocorticoids and their antagonists	0.034	0.966	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.033	0.967	0.000
T48.4 Expectorants	0.033	0.967	0.000
T48.3 Antitussives	0.033	0.967	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.033	0.967	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.033	0.967	0.000
T48.0 Oxytocic drugs	0.033	0.967	0.000
C00-C14 Malignant neoplasms of lip, oral cavity and pharynx	0.000	0.968	0.032
T45.1 Antineoplastic and immunosuppressive drugs	0.032	0.968	0.000
C02.1 Border of tongue	0.000	0.969	0.031
T48.6 Antiasthmatics, not elsewhere classified	0.031	0.969	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.031	0.969	0.000
C02 Malignant neoplasm of other and unspecified parts of tongue	0.000	0.969	0.031
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.031	0.969	0.000
C10 Malignant neoplasm of oropharynx	0.000	0.970	0.030
T40.6 Other and unspecified narcotics	0.029	0.971	0.000
T50.4 Drugs affecting uric acid metabolism	0.029	0.971	0.000
T48.5 Anti-common-cold drugs	0.029	0.971	0.000
T50.8 Diagnostic agents	0.029	0.971	0.000
C10.9 Oropharynx, unspecified	0.000	0.972	0.028
C45 Mesothelioma	0.028	0.972	0.000
C01 Malignant neoplasm of base of tongue	0.000	0.972	0.028
C45.0 Mesothelioma of pleura	0.028	0.972	0.000
C00 Malignant neoplasm of lip	0.000	0.972	0.028
C49 Malignant neoplasm of other connective and soft tissue	0.027	0.973	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.027	0.973	0.000
C07 Malignant neoplasm of parotid gland	0.000	0.973	0.027
C06 Malignant neoplasm of other and unspecified parts of mouth	0.000	0.973	0.027
C08 Malignant neoplasm of other and unspecified major salivary glands	0.000	0.974	0.026
C49.2 Connective and soft tissue of lower limb, including hip	0.026	0.974	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.025	0.975	0.000
C49.1 Connective and soft tissue of upper limb, including shoulder	0.025	0.975	0.000
Z94.8 Other transplanted organ and tissue status	0.025	0.975	0.000
C05 Malignant neoplasm of palate	0.000	0.975	0.025
C45.7 Mesothelioma of other sites	0.025	0.975	0.000
C02.4 Lingual tonsil	0.000	0.975	0.025
C49.3 Connective and soft tissue of thorax	0.025	0.975	0.000
C11 Malignant neoplasm of nasopharynx	0.000	0.975	0.024
C09 Malignant neoplasm of tonsil	0.000	0.975	0.024
C45.9 Mesothelioma, unspecified	0.024	0.976	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.024	0.976	0.000
C14 Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx	0.000	0.976	0.024
C13 Malignant neoplasm of hypopharynx	0.000	0.976	0.023
C03 Malignant neoplasm of gum	0.000	0.977	0.023
C04 Malignant neoplasm of floor of mouth	0.000	0.977	0.023
C08.9 Major salivary gland, unspecified	0.000	0.977	0.023
C00.0 External upper lip	0.000	0.977	0.023
C00.9 Lip, unspecified	0.000	0.977	0.023
C02.8 Overlapping lesion of tongue	0.000	0.977	0.022
C02.0 Dorsal surface of tongue	0.000	0.977	0.022
C02.3 Anterior two-thirds of tongue, part unspecified	0.000	0.978	0.022
C49.6 Connective and soft tissue of trunk, unspecified	0.022	0.978	0.000
C06.2 Retromolar area	0.000	0.978	0.022
C06.9 Mouth, unspecified	0.000	0.978	0.022
C10.8 Overlapping lesion of oropharynx	0.000	0.978	0.022
C10.4 Branchial cleft	0.000	0.978	0.022
C10.3 Posterior wall of oropharynx	0.000	0.978	0.022
C10.2 Lateral wall of oropharynx	0.000	0.978	0.022
C10.1 Anterior surface of epiglottis	0.000	0.978	0.022
C10.0 Vallecula	0.000	0.978	0.022
C49.0 Connective and soft tissue of head, face and neck	0.021	0.979	0.000
T42.4 Benzodiazepines	0.021	0.979	0.000
C12 Malignant neoplasm of pyriform sinus	0.000	0.979	0.021
H11.9 Disorder of conjunctiva, unspecified	0.021	0.979	0.000
C45.2 Mesothelioma of pericardium	0.020	0.979	0.000
C45.1 Mesothelioma of peritoneum	0.020	0.979	0.000
C02.9 Tongue, unspecified	0.000	0.979	0.020
C00.1 External lower lip	0.000	0.980	0.020
C00.8 Overlapping lesion of lip	0.000	0.980	0.020
C00.6 Commissure of lip	0.000	0.980	0.020
C00.5 Lip, unspecified, inner aspect	0.000	0.980	0.020
C00.4 Lower lip, inner aspect	0.000	0.980	0.020
C00.3 Upper lip, inner aspect	0.000	0.980	0.020
C00.2 External lip, unspecified	0.000	0.980	0.020
C25 Malignant neoplasm of pancreas	0.000	0.980	0.020
C49.8 Overlapping lesion of connective and soft tissue	0.020	0.980	0.000
T43.2 Other and unspecified antidepressants	0.020	0.980	0.000
C05.9 Palate, unspecified	0.000	0.980	0.020
H11.3 Conjunctival haemorrhage	0.020	0.980	0.000
C06.8 Overlapping lesion of other and unspecified parts of mouth	0.000	0.981	0.019
C06.1 Vestibule of mouth	0.000	0.981	0.019
C25.0 Head of pancreas	0.000	0.981	0.019
H11 Other disorders of conjunctiva	0.019	0.981	0.000
C08.8 Overlapping lesion of major salivary glands	0.000	0.981	0.019
C08.1 Sublingual gland	0.000	0.981	0.019
C49.4 Connective and soft tissue of abdomen	0.019	0.981	0.000
C02.2 Ventral surface of tongue	0.000	0.981	0.019
C11.9 Nasopharynx, unspecified	0.000	0.981	0.019
C05.0 Hard palate	0.000	0.981	0.019
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.018	0.981	0.000
C46 Kaposi's sarcoma	0.018	0.981	0.000
C09.9 Tonsil, unspecified	0.000	0.982	0.018
C05.8 Overlapping lesion of palate	0.000	0.982	0.018
C05.2 Uvula	0.000	0.982	0.018
C09.1 Tonsillar pillar (anterior) (posterior)	0.000	0.982	0.018
C05.1 Soft palate	0.000	0.982	0.018
C04.9 Floor of mouth, unspecified	0.000	0.982	0.018
C09.0 Tonsillar fossa	0.000	0.982	0.018
H11.1 Conjunctival degenerations and deposits	0.018	0.982	0.000
C09.8 Overlapping lesion of tonsil	0.000	0.982	0.018
C11.8 Overlapping lesion of nasopharynx	0.000	0.982	0.018
C11.3 Anterior wall of nasopharynx	0.000	0.982	0.018
C11.2 Lateral wall of nasopharynx	0.000	0.982	0.018
C11.1 Posterior wall of nasopharynx	0.000	0.982	0.018
C11.0 Superior wall of nasopharynx	0.000	0.982	0.018
C25.1 Body of pancreas	0.000	0.982	0.018
C03.9 Gum, unspecified	0.000	0.982	0.018
C13.9 Hypopharynx, unspecified	0.000	0.982	0.018
C25.2 Tail of pancreas	0.000	0.982	0.018
C03.0 Upper gum	0.000	0.982	0.018
C08.0 Submandibular gland	0.000	0.982	0.017
C25.3 Pancreatic duct	0.000	0.983	0.017
C14.0 Pharynx, unspecified	0.000	0.983	0.017
C14.8 Overlapping lesion of lip, oral cavity and pharynx	0.000	0.983	0.017
C14.2 Waldeyer's ring	0.000	0.983	0.017
C13.8 Overlapping lesion of hypopharynx	0.000	0.983	0.017
C13.2 Posterior wall of hypopharynx	0.000	0.983	0.017
C13.1 Aryepiglottic fold, hypopharyngeal aspect	0.000	0.983	0.017
C04.8 Overlapping lesion of floor of mouth	0.000	0.983	0.017
C04.1 Lateral floor of mouth	0.000	0.983	0.017
C25.9 Pancreas, unspecified	0.000	0.983	0.017
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.017	0.983	0.000
H11.8 Other specified disorders of conjunctiva	0.017	0.983	0.000
C13.0 Postcricoid region	0.000	0.983	0.016
C06.0 Cheek mucosa	0.000	0.984	0.016
C49.5 Connective and soft tissue of pelvis	0.016	0.984	0.000
C04.0 Anterior floor of mouth	0.000	0.984	0.016
C49.9 Connective and soft tissue, unspecified	0.016	0.984	0.000
C03.1 Lower gum	0.000	0.984	0.015
C25.4 Endocrine pancreas	0.000	0.984	0.015
C22 Malignant neoplasm of liver and intrahepatic bile ducts	0.000	0.985	0.015
C15-C26 Malignant neoplasms of digestive organs	0.000	0.985	0.015
C48.1 Specified parts of peritoneum	0.015	0.985	0.000
C20 Malignant neoplasm of rectum	0.000	0.985	0.015
C25.8 Overlapping lesion of pancreas	0.000	0.985	0.014
C24 Malignant neoplasm of other and unspecified parts of biliary tract	0.000	0.986	0.014
H11.2 Conjunctival scars	0.014	0.986	0.000
C25.7 Other parts of pancreas	0.000	0.986	0.014
C22.1 Intrahepatic bile duct carcinoma	0.000	0.986	0.014
C46.9 Kaposi's sarcoma, unspecified	0.013	0.986	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.013	0.986	0.000
C46.7 Kaposi's sarcoma of other sites	0.013	0.986	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.013	0.986	0.000
C46.2 Kaposi's sarcoma of palate	0.013	0.986	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.013	0.986	0.000
C46.0 Kaposi's sarcoma of skin	0.013	0.986	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.013	0.986	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.013	0.986	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.013	0.986	0.000
C47.5 Peripheral nerves of pelvis	0.013	0.986	0.000
C47.4 Peripheral nerves of abdomen	0.013	0.986	0.000
C47.3 Peripheral nerves of thorax	0.013	0.986	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.013	0.986	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.013	0.986	0.000
C47.0 Peripheral nerves of head, face and neck	0.013	0.986	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.014	0.986	0.000
C22.0 Liver cell carcinoma	0.000	0.987	0.013
C24.1 Ampulla of Vater	0.000	0.987	0.013
C21 Malignant neoplasm of anus and anal canal	0.000	0.987	0.013
C22.9 Liver, unspecified	0.000	0.987	0.013
O36.5 Maternal care for poor foetal growth	0.013	0.987	0.000
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.012	0.988	0.000
C24.0 Extrahepatic bile duct	0.000	0.988	0.012
C21.0 Anus, unspecified	0.000	0.988	0.012
N13.4 Hydroureter	0.011	0.989	0.000
C22.7 Other specified carcinomas of liver	0.000	0.989	0.011
C22.4 Other sarcomas of liver	0.000	0.989	0.011
C22.3 Angiosarcoma of liver	0.000	0.989	0.011
C22.2 Hepatoblastoma	0.000	0.989	0.011
C24.9 Biliary tract, unspecified	0.000	0.989	0.011
C23 Malignant neoplasm of gallbladder	0.000	0.989	0.011
C21.8 Overlapping lesion of rectum, anus and anal canal	0.000	0.989	0.011
C24.8 Overlapping lesion of biliary tract	0.000	0.989	0.010
C16 Malignant neoplasm of stomach	0.000	0.989	0.011
C48.0 Retroperitoneum	0.010	0.990	0.000
C17 Malignant neoplasm of small intestine	0.000	0.990	0.010
C19 Malignant neoplasm of rectosigmoid junction	0.000	0.990	0.010
C21.2 Cloacogenic zone	0.000	0.990	0.009
Z94 Transplanted organ and tissue status	0.009	0.991	0.000
O36.0 Maternal care for rhesus isoimmunisation	0.009	0.991	0.000
C16.5 Lesser curvature of stomach, unspecified	0.000	0.991	0.009
C16.6 Greater curvature of stomach, unspecified	0.000	0.991	0.009
O36 Maternal care for other known or suspected foetal problems	0.009	0.991	0.000
C26 Malignant neoplasm of other and ill-defined digestive organs	0.000	0.992	0.008
C16.4 Pylorus	0.000	0.992	0.008
C16.1 Fundus of stomach	0.000	0.992	0.008
C48.2 Peritoneum, unspecified	0.008	0.992	0.000
C16.3 Pyloric antrum	0.000	0.992	0.008
O36.4 Maternal care for intra-uterine death	0.008	0.992	0.000
Z94.0 Kidney transplant status	0.008	0.992	0.000
C16.2 Body of stomach	0.000	0.992	0.008
C16.8 Overlapping lesion of stomach	0.000	0.992	0.008
D37.7 Other digestive organs	0.008	0.992	0.000
C17.8 Overlapping lesion of small intestine	0.000	0.993	0.007
C17.3 Meckel's diverticulum	0.000	0.993	0.007
C17.0 Duodenum	0.000	0.993	0.007
Z94.4 Liver transplant status	0.007	0.993	0.000
Z94.3 Heart and lungs transplant status	0.007	0.993	0.000
C17.1 Jejunum	0.000	0.993	0.007
Z94.5 Skin transplant status	0.007	0.993	0.000
C21.1 Anal canal	0.000	0.993	0.007
C17.2 Ileum	0.000	0.993	0.007
K85.9 Acute pancreatitis, unspecified	0.007	0.993	0.000
Z94.6 Bone transplant status	0.007	0.993	0.000
O36.3 Maternal care for signs of foetal hypoxia	0.007	0.993	0.000
C17.9 Small intestine, unspecified	0.000	0.993	0.007
O36.2 Maternal care for hydrops foetalis	0.007	0.993	0.000
Z94.2 Lung transplant status	0.007	0.993	0.000
O36.1 Maternal care for other isoimmunisation	0.006	0.993	0.000
Z30.1 Insertion of (intra-uterine) contraceptive device	0.007	0.993	0.000
Z94.9 Transplanted organ and tissue status, unspecified	0.006	0.994	0.000
C26.8 Overlapping lesion of digestive system	0.000	0.994	0.006
C26.1 Spleen	0.000	0.994	0.006
C15 Malignant neoplasm of oesophagus	0.000	0.994	0.006
Z94.1 Heart transplant status	0.006	0.994	0.000
K85.1 Biliary acute pancreatitis	0.006	0.994	0.000
H10-H13 Disorders of conjunctiva	0.006	0.994	0.000
K85 Acute pancreatitis	0.006	0.994	0.000
O36.7 Maternal care for viable foetus in abdominal pregnancy	0.006	0.994	0.000
K85.2 Alcohol-induced acute pancreatitis	0.006	0.994	0.000
Z94.7 Corneal transplant status	0.006	0.994	0.000
C26.9 Ill-defined sites within the digestive system	0.000	0.994	0.005
C15.3 Upper third of oesophagus	0.000	0.994	0.005
O36.6 Maternal care for excessive foetal growth	0.005	0.995	0.000
O36.9 Maternal care for foetal problem, unspecified	0.005	0.995	0.000
C15.0 Cervical part of oesophagus	0.000	0.995	0.005
H11.0 Pterygium	0.005	0.995	0.000
H13 Disorders of conjunctiva in diseases classified elsewhere	0.005	0.995	0.000
C15.1 Thoracic part of oesophagus	0.000	0.995	0.005
C16.0 Cardia	0.000	0.995	0.005
C26.0 Intestinal tract, part unspecified	0.000	0.995	0.005
D37.0 Lip, oral cavity and pharynx	0.005	0.995	0.000
C15.8 Overlapping lesion of oesophagus	0.000	0.995	0.004
C15.2 Abdominal part of oesophagus	0.000	0.995	0.004
W19.2 School, other institution and public administrative area	0.000	0.995	0.005
K85.3 Drug-induced acute pancreatitis	0.004	0.995	0.000
L82 Seborrhoeic keratosis	0.000	0.996	0.004
B35.1 Tinea unguium	0.000	0.996	0.004
K85.0 Idiopathic acute pancreatitis	0.004	0.996	0.000
Q23.1 Congenital insufficiency of aortic valve	0.000	0.996	0.004
C81.9 Hodgkin's disease, unspecified	0.004	0.996	0.000
T31.0 Burns involving less than 10% of body surface	0.004	0.996	0.000
C15.4 Middle third of oesophagus	0.000	0.996	0.004
H13.1 Conjunctivitis in infectious and parasitic diseases classified elsewhere	0.004	0.996	0.000
H13.3 Ocular pemphigoid	0.004	0.996	0.000
C81.1 Nodular sclerosis	0.004	0.996	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.004	0.996	0.000
B35.3 Tinea pedis	0.000	0.996	0.004
K85.8 Other acute pancreatitis	0.004	0.996	0.000
H13.8 Other disorders of conjunctiva in diseases classified elsewhere	0.004	0.996	0.000
H13.2 Conjunctivitis in other diseases classified elsewhere	0.004	0.996	0.000
H13.0 Filarial infection of conjunctiva	0.004	0.996	0.000
G72.9 Myopathy, unspecified	0.004	0.996	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.000	0.996	0.004
C16.9 Stomach, unspecified	0.000	0.996	0.004
D04.3 Skin of other and unspecified parts of face	0.000	0.996	0.004
D37.5 Rectum	0.004	0.996	0.000
C81 Hodgkin's disease	0.004	0.996	0.000
M54.59 Low back pain (Site unspecified)	0.003	0.997	0.000
D04.7 Skin of lower limb, including hip	0.000	0.997	0.003
H05.8 Other disorders of orbit	0.000	0.997	0.003
B35 Dermatophytosis	0.000	0.997	0.003
Z86.2 Personal history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.997	0.003
N13.9 Obstructive and reflux uropathy, unspecified	0.003	0.997	0.000
D37.1 Stomach	0.003	0.997	0.000
G72 Other myopathies	0.003	0.997	0.000
C53.9 Cervix uteri, unspecified	0.003	0.997	0.000
C81.2 Mixed cellularity	0.003	0.997	0.000
T31 Burns classified according to extent of body surface involved	0.003	0.997	0.000
N13.3 Other and unspecified hydronephrosis	0.003	0.997	0.000
K22.5 Diverticulum of oesophagus, acquired	0.000	0.997	0.003
C71.2 Temporal lobe	0.000	0.997	0.003
J33.9 Nasal polyp, unspecified	0.000	0.997	0.003
S22.40 Multiple fractures of ribs (closed)	0.003	0.997	0.000
H05.2 Exophthalmic conditions	0.000	0.997	0.003
H05 Disorders of orbit	0.000	0.997	0.003
H05.0 Acute inflammation of orbit	0.000	0.997	0.003
D37.3 Appendix	0.003	0.997	0.000
C81.0 Lymphocytic predominance	0.003	0.997	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.000	0.997	0.003
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.003	0.997	0.000
C81.3 Lymphocytic depletion	0.003	0.997	0.000
X63.0 Home	0.003	0.997	0.000
C92.0 Acute myeloid leukaemia	0.003	0.997	0.000
D04 Carcinoma in situ of skin	0.000	0.997	0.003
G72.4 Inflammatory myopathy, not elsewhere classified	0.003	0.997	0.000
N13 Obstructive and reflux uropathy	0.003	0.997	0.000
D37.9 Digestive organ, unspecified	0.003	0.997	0.000
K70.9 Alcoholic liver disease, unspecified	0.000	0.997	0.003
T31.1 Burns involving 10-19% of body surface	0.003	0.997	0.000
B35.8 Other dermatophytoses	0.000	0.997	0.003
B35.5 Tinea imbricata	0.000	0.997	0.003
B35.2 Tinea manuum	0.000	0.997	0.003
B35.0 Tinea barbae and tinea capitis	0.000	0.997	0.003
G72.1 Alcoholic myopathy	0.003	0.997	0.000
T90.2 Sequelae of fracture of skull and facial bones	0.003	0.997	0.000
M47.9 Spondylosis, unspecified	0.000	0.997	0.003
R23.1 Pallor	0.003	0.997	0.000
C81.7 Other Hodgkin's disease	0.002	0.997	0.000
G72.8 Other specified myopathies	0.002	0.997	0.000
G72.0 Drug-induced myopathy	0.002	0.997	0.000
H05.9 Disorder of orbit, unspecified	0.000	0.997	0.003
Q52.5 Fusion of labia	0.000	0.997	0.003
H05.1 Chronic inflammatory disorders of orbit	0.000	0.997	0.002
I44.3 Other and unspecified atrioventricular block	0.003	0.997	0.000
X60.8 Other specified place	0.003	0.997	0.000
M87.95 Osteonecrosis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
G72.3 Periodic paralysis	0.002	0.997	0.000
G72.2 Myopathy due to other toxic agents	0.002	0.997	0.000
B35.6 Tinea cruris	0.000	0.997	0.002
T31.9 Burns involving 90% or more of body surface	0.002	0.997	0.000
T31.8 Burns involving 80-89% of body surface	0.002	0.997	0.000
T31.7 Burns involving 70-79% of body surface	0.002	0.997	0.000
T31.6 Burns involving 60-69% of body surface	0.002	0.997	0.000
T31.5 Burns involving 50-59% of body surface	0.002	0.997	0.000
T31.4 Burns involving 40-49% of body surface	0.002	0.997	0.000
T31.3 Burns involving 30-39% of body surface	0.002	0.997	0.000
T31.2 Burns involving 20-29% of body surface	0.002	0.997	0.000
D04.0 Skin of lip	0.000	0.997	0.002
H10 Conjunctivitis	0.002	0.997	0.000
B35.4 Tinea corporis	0.000	0.997	0.002
D04.4 Skin of scalp and neck	0.000	0.998	0.002
Z93.3 Colostomy status	0.000	0.998	0.002
M47.99 Spondylosis, unspecified (Site unspecified)	0.000	0.998	0.002
G71.0 Muscular dystrophy	0.002	0.998	0.000
H05.5 Retained (old) foreign body following penetrating wound of orbit	0.000	0.998	0.002
H05.3 Deformity of orbit	0.000	0.998	0.002
S56.1 Injury of flexor muscle and tendon of other finger(s) at forearm level	0.002	0.998	0.000
G71 Primary disorders of muscles	0.002	0.998	0.000
M47.12 Other spondylosis with myelopathy (Cervical region)	0.000	0.998	0.002
D04.1 Skin of eyelid, including canthus	0.000	0.998	0.002
B35.9 Dermatophytosis, unspecified	0.000	0.998	0.002
G71.3 Mitochondrial myopathy, not elsewhere classified	0.002	0.998	0.000
K13.0 Diseases of lips	0.000	0.998	0.002
Q28.2 Arteriovenous malformation of cerebral vessels	0.002	0.998	0.000
Q23 Congenital malformations of aortic and mitral valves	0.000	0.998	0.002
D37.2 Small intestine	0.002	0.998	0.000
G70-G73 Diseases of myoneural junction and muscle	0.002	0.998	0.000
Y40.0 Penicillins	0.000	0.998	0.002
R22.1 Localised swelling, mass and lump, neck	0.002	0.998	0.000
K37 Unspecified appendicitis	0.002	0.998	0.000
T90 Sequelae of injuries of head	0.002	0.998	0.000
D04.8 Skin of other sites	0.000	0.998	0.002
I22.9 Subsequent myocardial infarction of unspecified site	0.002	0.998	0.000
H05.4 Enophthalmos	0.000	0.998	0.002
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.000	0.998	0.002
C71.1 Frontal lobe	0.002	0.998	0.000
H70.9 Mastoiditis, unspecified	0.002	0.998	0.000
S00.1 Contusion of eyelid and periocular area	0.002	0.998	0.000
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
S56 Injury of muscle and tendon at forearm level	0.002	0.998	0.000
S01.2 Open wound of nose	0.002	0.998	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.002
F06.7 Mild cognitive disorder	0.002	0.998	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.000	0.998	0.002
S22.4 Multiple fractures of ribs	0.002	0.998	0.000
T90.5 Sequelae of intracranial injury	0.002	0.998	0.000
T90.0 Sequelae of superficial injury of head	0.002	0.998	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.000	0.998	0.002
S56.8 Injury of other and unspecified muscles and tendons at forearm level	0.002	0.998	0.000
G70 Myasthenia gravis and other myoneural disorders	0.002	0.998	0.000
Z71.8 Other specified counselling	0.002	0.998	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.000	0.998	0.002
H10.5 Blepharoconjunctivitis	0.002	0.998	0.000
H10.2 Other acute conjunctivitis	0.002	0.998	0.000
X63 Intentional self-poisoning by and exposure to other drugs acting on the autonomic nervous system	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations